Home » Business, Health & Medicine, Manufacturing & Industry, Marketing & Sales, Pharmaceuticals & Biotech » Tissue Diagnostic Market is Expected to Reach USD 6.4 billion by 2022 Research Report by Hexa Reports Inc.
Tissue diagnostic, due to its ability to detect cancer at an early stage, is expected to witness significant growth over the forecast period. Increasing incidences of breast cancer, rising geriatric population base and the growing demand for personalized medicines are high impact rendering drivers of the tissue diagnostics market.

Tissue diagnostic procedures encompass a broad array of technologies designed to revolutionize the cancer diagnosis process and provide apt molecular information. Tissue diagnostic detects the presence of malignant cells by performing microscopic study of the involved tissue. This investigation is considered to be vital for any type of cancer in order to decide the most effective treatment line. Furthermore, improving healthcare infrastructure, increasing demand for safe and cost effective treatment and rising focus of major market players on emerging economies such as India and China are likely to propel market growth. Technological advancement occurring in the field of tissue diagnostics is expected to lead towards the availability of better option for healthcare professionals and the patients.

Browse Detailed Report with TOC at:

Further key findings from the study suggest:

Immunohistochemistry (IHC) is identified as the most lucrative sub segment of the tissue diagnostic market majorly owing to increasing incidences of cancer diagnostic

The tissue based breast cancer diagnostic segment accounted for the largest market share in 2014. Rising alcohol consumption, lifestyle associated changes and growing geriatric population are some factors expected to drive segment growth over the forecast period.

North America accounted for over 40.0% of the tissue diagnostic market in 2014 on account of high usage rates of technologically advanced products. Rising patient awareness level and the presence of accessible healthcare infrastructure is also expected to contribute towards healthy regional market growth.

Asia Pacific is expected to witness the fastest growth over the forecast period. Rapid economic development and the consequent improvement of the healthcare infrastructure is expected to help manufacturers capitalize on the available opportunities in the form of unmet medical needs. Presence of sophisticated healthcare facilities in the developed markets of Japan and Australia is also expected to boost usage rates over the forecast period.

Key players of the tissue diagnostic market include Roche Diagnostics, Cell Signaling Technologies, Becton Dickinson & Company, Agilent Technologies, Abbott Laboratories, GE Healthcare, Thermo Fisher Scientific, Johnson & Johnson and Danaher Corporation.

Browse Healthcare Related Research Reports at:

For the purpose of this study, Grand View Research has segmented the global tissue diagnostic market on the basis of products, technology, application, end-use and region:

Global Tissue Diagnostic Product Outlook (Revenue, USD Million, 2012 – 2022)

Global Tissue Diagnostic Technology Outlook (Revenue, USD Million, 2012 – 2022)

Immunohistochemistry (IHC)
In Situ Hybridization
Special Staining
Digital Pathology and Workflow

Request a Sample copy of This Report at:

Global Tissue Diagnostic Application Outlook (Revenue, USD Million, 2012 – 2022)

Breast Cancer
Gastric Cancer
Prostate Cancer
Non Small Cell Lung Cancer

Global Tissue Diagnostic End-use Outlook (Revenue, USD Million, 2012 – 2022)

Contract Research Organization (CRO)
Pharmaceutical Organizations
Research Laboratories

Browse Our Market Research Reports Countrywise at:

Table of Contents

Chapter 1. Methodology and Scope
1.1. Research methodology
1.2. Research scope & assumption
1.3. List of data sources Chapter
2. Executive Summary
2.1. Tissue Diagnostic Market – Industry Summary and Key Buying Criteria, 2012 – 2022
Chapter 3. Tissue Diagnostic Industry Outlook
3.1. Tissue Diagnostic Market Segmentation
3.2. Tissue Diagnostic Market Size And Growth Prospects
3.3. Tissue Diagnostic Market Dynamics
3.3.1. Market Driver Analysis
Chapter 4. Tissue Diagnostic Market Product Outlook
4.1. Tissue Diagnostic Market Share By Product, 2014 & 2022
4.2. Instruments Market Estimates And Forecasts, 2012 – 2022 (USD Million)
4.3. Accessories Market Estimates And Forecasts, 2012 – 2022 (USD Million)
Chapter 5. Tissue Diagnostic Market Technology Outlook
5.1. Tissue Diagnostic Market Share By Technology, 2014 & 2022
5.2. Immunohistochemistry (IHC) Market Estimates And Forecasts, 2012 – 2022 (USD Million)
5.3. In situ Hybridization Market Estimates And Forecasts, 2012 – 2022 (USD Million)
5.4. Special Staining Market Estimates And Forecasts, 2012 – 2022 (USD Million)
5.5. Digital Pathology & Workflow Market Estimates And Forecasts, 2012 – 2022 (USD Million)

For More Information, Visit:

About Us:

Hexa Reports Inc. is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe.We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Media Contact
Company Name: Hexa Reports
Contact Person: Ryan Shaw
Email: sales@hexareports.com
Phone: 1-800-489-3075
Address:Felton Office Plaza, 6265 Highway 9
City: Felton
State: California
Country: United States
Website: http://www.hexareports.com/report/tissue-diagnostic-market-analysis-by-product-instruments-accessories-by-technology-ihc-special-staining-in-situ-hybridization-digital-pathology-amp-workflow-by-application-breast-cancer-prostate-cancer-lymphoma-cancer-gastric-cancer-non-small-cell-lung-cancer-by-end-use-hospitals-cro-research-laboratories-and-segment-forecasts-to-2022/details

Comments are closed.